Literature DB >> 26601793

Quality and safety control of tumor-shrinking decoction (TSD): A Chinese herbal preparation for the treatment of uterine fibroids.

Xiao-Xin Chen1, Wai Ling Lin1, Wing Fai Yeung1, Tian-He Song1, Li-Xing Lao1, Yan-Bo Zhang1, Wei Meng1.   

Abstract

Reproducible efficacy assessments of Chinese herbal medicines are largely based on well-established quality control procedures. This study presents a comprehensive quality control procedure for tumor-shrinking decoction (TSD), a 15-herb preparation under study as a potential therapy for uterine fibroids. Morphological, microscopic, and physicochemical authentications were first carried out on individual herbal medicines composing TSD. Contaminant tests on TSD for the presence of heavy metals and pesticide residues were performed by atomic absorption spectrophotometry and gas chromatography-mass spectrometry analysis. Furthermore, batch-to-batch quality monitoring of the decoction was investigated via ultra-performance liquid chromatography (UPLC) and high-performance liquid chromatography (HPLC). An aqueous extract of the herbal medicines was prepared and formulated into TSD. The tested contaminants were within the maximum permitted levels of the Hong Kong government in proprietary Chinese medicines. UPLC and HPLC fingerprints for quality tracking on TSD were established. The decoction was quantitatively standardized by UPLC and HPLC, respectively, with five and three chemical compounds serving as references. Collectively, the procedure established in this study will not only serve as a fundamental basis for the investigation and development of TSD as a novel therapy for uterine fibroids, but also as a protocol for studying other polycomponent herbal preparations.
© 2015 International Union of Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  chemical fingerprint; heavy metals; herbal preparation; pesticide residues; quality control; reference compounds

Mesh:

Substances:

Year:  2016        PMID: 26601793     DOI: 10.1002/bab.1460

Source DB:  PubMed          Journal:  Biotechnol Appl Biochem        ISSN: 0885-4513            Impact factor:   2.431


  5 in total

1.  Efficacy and safety of traditional Chinese herbal formula combined with western medicine for uterine fibroid: A protocol for systematic review and meta-analysis.

Authors:  Yu Fu; Yihua Fan; Wei Fan; Yubing Lv; Siyu Ai; Chenghao Yu
Journal:  Medicine (Baltimore)       Date:  2020-09-04       Impact factor: 1.889

2.  Neuroprotective effect of a novel Chinese herbal decoction on cultured neurons and cerebral ischemic rats.

Authors:  Fanny Chui-Fun Ip; Yu-Ming Zhao; Kim-Wan Chan; Elaine Yee-Ling Cheng; Estella Pui-Sze Tong; Oormila Chandrashekar; Guang-Miao Fu; Zhong-Zhen Zhao; Nancy Yuk-Yu Ip
Journal:  BMC Complement Altern Med       Date:  2016-11-04       Impact factor: 3.659

3.  Gyejibongneyong-hwan, a herbal medicine for the treatment of dysmenorrhoea with uterine fibroids: a protocol for a randomised controlled trial.

Authors:  Jeeyoun Jung; Ju Ah Lee; Mi Mi Ko; Sooseong You; Eunhee Lee; Jiae Choi; Byoung-Kab Kang; Myeong Soo Lee
Journal:  BMJ Open       Date:  2016-11-24       Impact factor: 2.692

4.  Successful Pregnancy after Treatment with Chinese Herbal Medicine in a 43-Year-Old Woman with Diminished Ovarian Reserve and Multiple Uterus Fibrosis: A Case Report.

Authors:  Benqi Teng; Jie Peng; Madeleine Ong; Xianqin Qu
Journal:  Medicines (Basel)       Date:  2017-02-09

5.  Efficacy of modified Banxia Xiexin decoction in the management of Wei-Pi syndrome (postprandial distress syndrome): study protocol for a randomized, waitlist-controlled trial.

Authors:  Sai Ho Sin; Jing Wu; Yuchen Kang; Kar Hung Kevin Yip; Ngo Suet Kong; Hei Wan; Bacon Fung Leung Ng; Haiyong Chen
Journal:  Trials       Date:  2021-02-12       Impact factor: 2.279

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.